Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 42708-190

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 42708-190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg Label (42708 190 30 Label.jpg)

Label for Rosuvastatin Tablets USP 10 mg, containing 30 film-coated tablets by QPharma, Inc. The label includes dosage instructions to be seen in the package insert, storage instructions to keep at controlled room temperature, and safety notes to keep out of reach of children and keep the container tightly closed. The label also states it is a sample not for sale and for prescription use only.*

FDA Label Image

Label (42708 191 30 Label.jpg)

Label for Rosuvastatin Tablets USP 20 mg, film-coated oral tablets in a 30-count package. The label includes dosage instructions sections, storage advice to keep at controlled room temperature, and a note that it is a sample not for sale. The labeler is QPharma, Inc., with their location in Cedar Knolls, NJ. It is marked Rx Only.*

FDA Label Image

Figure1 (Figure1)

A line graph showing cumulative incidence percentage over a 6-year period for Rosuvastatin calcium (R SUV) compared to placebo. The graph includes hazard ratio (HR 0.56, 95% CI 0.46-0.69) and a significance value (P<0.001). Below the graph, a table shows the number of subjects at risk for each group at multiple time points.*

FDA Label Image

Figure2 (Figure2)

A data table comparing the number of events for various cardiovascular endpoints between Rosuvastatin calcium 20 mg and placebo 20 mg groups. The table includes event rates per 1000 patient-years, hazard ratios with 95% confidence intervals, and p-values, alongside a forest plot of hazard ratios for endpoints such as primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization.*

FDA Label Image

Figure3 (Figure3)

A box plot chart comparing percent change from baseline LDL-C levels for four statins: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. Dose levels in mg are indicated above each drug name. The y-axis shows percent change, ranging from 0 to -75, demonstrating LDL-C reduction at various dosages.*

FDA Label Image

Logo (Logo)

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Structure (Structure)

Chemical structure of rosuvastatin calcium, showing the molecular arrangement including fluorophenyl, sulfonamide, hydroxy, and carboxylate groups, along with the calcium ion (Ca2+) complexed in the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.